By applying ROC curve analysis (47), we also demonstrated the predictive value of Cluster C1 signature for the liver cancerization and the CD8 Tem/CTL-based immune infiltration in three separate cohorts of patients with eHCC. The gene discussed is CD8A; the disease is liver cancer.